Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study

被引:217
作者
Abbott, KC [1 ]
Glanton, CW
Trespalacios, FC
Oliver, DK
Ortiz, MI
Agodoa, LY
Cruess, DF
Kimmel, PL
机构
[1] Walter Reed Army Med Ctr, Serv Nephrol, Washington, DC 20307 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[3] Wilford Hall USAF Med Ctr, Serv Nephrol, Lackland AFB, TX 78236 USA
[4] Madigan Army Med Ctr, Serv Nephrol, Ft Lewis, WA USA
[5] NIDDK, NIH, Bethesda, MD USA
[6] George Washington Hosp Ctr, Serv Nephrol, Washington, DC USA
关键词
obesity; body mass index; peritoneal dialysis; hemodialysis; survival; mortality;
D O I
10.1111/j.1523-1755.2004.00385.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. The impact of obesity on survival in end-stage renal disease (ESRD) patients as related to dialysis modality (i.e., a direct comparison of hemodialysis with peritoneal dialysis) has not been assessed adjusting for differences in medication use, follow-up 2 years, or accounting for changes in dialysis modality. Methods. We performed a retrospective cohort study of the United States Renal Data System (USRDS) Dialysis Morbidity and Mortality Wave II Study (DMMS) patients who started dialysis in 1996, and were followed until October 31 2001. Cox regression analysis was used to model adjusted hazard ratios (AHR) for mortality for categories of body mass index (BMI), both as quartiles and as greater than or equal to30 kg/m(2) vs. lower. Because such a large proportion of peritoneal dialysis patients changed to hemodialysis during the study period (45.5%), a sensitivity analysis was performed calculating survival time both censoring and not censoring on the date of change from peritoneal dialysis to hemodialysis. Results. There were 1675 hemodialysis and 1662 peritoneal dialysis patients. Among hemodialysis patients, 5-year survival for patients with BMI greater than or equal to30 kg/m(2) was 39.8% vs. 32.3% for lower BMI (P < 0.01 by log-rank test). Among peritoneal dialysis patients, 5-year survival for patients with BMI 30 kg/m(2) was 38.7% vs. 40.4% for lower BMI (P > 0.05 by log-rank test). In adjusted analysis, BMI greater than or equal to30 kg/m(2) was associated with improved survival in hemodialysis patients (AHR 0.89; 95% CI 0.81, 0.99; P = 0.042) but not peritoneal dialysis patients (AHR = 0.99; 95% CI, 0.86, 1.15; P = 0.89). Results were not different on censoring of change from peritoneal dialysis to hemodialysis. Conclusion. We conclude that any survival advantage associated with obesity among chronic dialysis patients is significantly less likely for peritoneal dialysis patients, compared to hemodialysis patients.
引用
收藏
页码:597 / 605
页数:9
相关论文
共 42 条
[1]  
Aslam N, 2002, PERITON DIALYSIS INT, V22, P191
[2]   Association between residual renal function inflammation and patient survival in new peritoneal dialysis patients [J].
Chung, SH ;
Heimbürger, O ;
Stenvinkel, P ;
Qureshi, AR ;
Lindholm, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (03) :590-597
[3]   Mortality risks of peritoneal dialysis and hemodialysis [J].
Collins, AJ ;
Hao, WL ;
Xia, H ;
Ebben, JP ;
Everson, SE ;
Constantini, EG ;
Ma, JZ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) :1065-1074
[4]   Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients [J].
Combe, C ;
Chauveau, P ;
Laville, M ;
Fouque, D ;
Azar, R ;
Cano, N ;
Canaud, B ;
Roth, H ;
Leverve, X ;
Aparicio, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (01) :S81-S88
[5]   Effect of dialysis dose and membrane flux in maintenance hemodialysis. [J].
Eknoyan, G ;
Beck, GJ ;
Cheung, AK ;
Daugirdas, JT ;
Greene, T ;
Kusek, JW ;
Allon, M ;
Bailey, J ;
Delmez, JA ;
Depner, TA ;
Dwyer, JT ;
Levey, AS ;
Levin, NW ;
Milford, E ;
Ornt, DB ;
Rocco, MV ;
Schulman, G ;
Schwab, SJ ;
Teehan, BP ;
Toto, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2010-2019
[6]   Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients [J].
Fleischmann, E ;
Teal, N ;
Dudley, J ;
May, W ;
Bower, JD ;
Salahudeen, AK .
KIDNEY INTERNATIONAL, 1999, 55 (04) :1560-1567
[7]   Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index [J].
Glanton, CW ;
Kao, TC ;
Cruess, D ;
Agodoa, LYC ;
Abbott, KC .
KIDNEY INTERNATIONAL, 2003, 63 (02) :647-653
[8]   Factors associated with improved short term survival in obese end stage renal disease patients [J].
Glanton, CW ;
Hypolite, IO ;
Hshieh, PB ;
Agodoa, LY ;
Yuan, CM ;
Abbott, KC .
ANNALS OF EPIDEMIOLOGY, 2003, 13 (02) :136-143
[9]   Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients [J].
Iseki, K ;
Yamazato, M ;
Tozawa, M ;
Takishita, S .
KIDNEY INTERNATIONAL, 2002, 61 (05) :1887-1893
[10]  
Johnson DW, 2000, PERITON DIALYSIS INT, V20, P715